NCT01575600

Brief Summary

The purpose of this randomized clinical trial is to evaluate the interaction of intravenous fluid therapy during otorhinolaryngological surgery, on postoperative vomiting. The hypothesis is that perioperative supplemental intravenous fluid administration reduces the incidence of postoperative vomiting.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Jul 2010

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2010

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2012

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 10, 2012

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 11, 2012

Completed
Last Updated

May 10, 2012

Status Verified

May 1, 2012

Enrollment Period

1.7 years

First QC Date

April 10, 2012

Last Update Submit

May 8, 2012

Conditions

Outcome Measures

Primary Outcomes (1)

  • Vomiting at 24 hours postoperative

    Presence of at least one episode of vomiting in the first 24 hours postoperative

    First 24 hours postoperative

Study Arms (2)

10 mL/kg/h lactated Ringer's solution

ACTIVE COMPARATOR

Group 1, 10 mL/kg/h lactated Ringer's solution

Other: Intraoperative lactated Ringer's solution

30 mL/kg/h lactated Ringer's solution

EXPERIMENTAL

Group 2, 30 mL/kg/h lactated Ringer's solution

Other: Intraoperative lactated Ringer's solution

Interventions

After induction, IV access was established and children were randomly allocated to receive one of two interventions: Group 1, 10 mL/kg/h lactated Ringer's solution; Group 2, 30 mL/kg/h lactated Ringer's solution.

10 mL/kg/h lactated Ringer's solution30 mL/kg/h lactated Ringer's solution

Eligibility Criteria

Age1 Year - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • ASA physical status I or II
  • Age 1-12 yr
  • Scheduled for elective tonsillectomy or adenotonsillectomy

You may not qualify if:

  • History of diabetes
  • History of mental retardation
  • Obesity (BMI ≥95th percentile for age and sex)
  • Intake of antiemetic or psychoactive medication within 24 hours before surgery
  • Known gastroesophageal reflux

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Clinico Universidad Catolica

Santiago, Santiago Metropolitan, Chile

Location

MeSH Terms

Conditions

Postoperative Nausea and Vomiting

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNauseaSigns and Symptoms, DigestiveSigns and SymptomsVomiting

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Profesor Asociado, Departamento de Anestesiología

Study Record Dates

First Submitted

April 10, 2012

First Posted

April 11, 2012

Study Start

July 1, 2010

Primary Completion

March 1, 2012

Study Completion

March 1, 2012

Last Updated

May 10, 2012

Record last verified: 2012-05

Locations